filmov
tv
Identifying Connective Tissue Disease—Associated PAH
Показать описание
Focusing on CTD-PAH, key opinion leaders discuss how the disease can be identified and relevant impact on quality of life.
Identifying Connective Tissue Disease—Associated PAH
Understanding CTD-PAH: An Overview
CTD-PAH: Adjusting Treatment Based on Patient Factors
CTD-PAH: Overview of Treatment Strategies
The Burden of CTD-PAH: Patient Perspectives
Pulmonary Hypertension in Systemic Sclerosis in the Current Era- Lorinda Chung, M.D., M.S.- 2018
Identifying Subpopulations of PH and PAH
When Is It a Connective Tissue Disease
Pulmonary Arterial Hypertension and Connective Tissue Disease
An introduction to Connective Tissue Disease-associated Interstitial Lung Disease (CTD-ILD) webinar
Overlapping Syndromes: MCTD, UCTD, Just a Lot of Letters, Virginia Steen, MD
What Evidence Supports Use of Combination Therapies in Treating CTD-PAH?
Dr. Niranjan Jeganathan - Connective Tissue Disease-Associated Interstitial Lung Disease
Management of Connective Tissue Disease Associated Interstitial Lung Disease (CTD-ILD)
Immunosuppression in the treatment of CTD-PAH
Scleroderma and Pulmonary Arterial Hypertension
Screening Mandates for Patients with CTD: Improving PAH Identification
Pulmonary Hypertension and Connective tissue disease
PH in ILD: Finally some hope?- Kristin Highland, MD
The Effect of Delayed Diagnosis of PAH and Identifying Patients Earlier
Systemic sclerosis-associated pulmonary arterial hypertension (PAHT)
S1 Episode 1: Connective Tissue Disease-Interstitial Lung Disease
Diagnosis and management of PAH Recommendations ESC/ERS 2022
Multidisciplinary Management of Connective Tissue Disease-Associated Interstitial Lung Diseases
Комментарии